Table 2 Prevalence of NOD2 3020insC mutation in breast cancer patients, according to age at onset
From: Pilot Study on Low Penetrance Breast and Colorectal Cancer Predisposition Markers in Latvia
Age groups | Prevalence of NOD2 3020insC |
|---|---|
<41 | 0% (0/10) |
41-50 | 9.7% (3/31) |
51-60 | 17% (8/46)* |
61-70 | 7.3% (4/55) |
>70 | 4.9% (2/41) |
total | 9.1% (17/185) |